Literature DB >> 19317611

Closed head injury in a mouse model results in molecular changes indicating inflammatory responses.

Charlotte Israelsson1, Yun Wang, Annika Kylberg, Chaim G Pick, Barry J Hoffer, Ted Ebendal.   

Abstract

Cerebral gene expression changes in response to traumatic brain injury will provide useful information in the search for future trauma treatment. In order to characterize the outcome of mild brain injury, we studied C57BL/6J mice in a weight-drop, closed head injury model. At various times post-injury, mRNA was isolated from neocortex and hippocampus and transcriptional alterations were studied using quantitative reverse transcriptase PCR and gene array analysis. At three days post-injury, the results showed unilateral injury responses, both in neocortex and hippocampus, with the main effect seen on the side of the skull hit by the dropping weight. Upregulated transcripts encoded products characterizing reactive astrocytes, phagocytes, microglia, and immune-reactive cells. Markers for oligodendrocytes and T-cells were not altered. Notably, strong differences in the responses among individual mice were seen (e.g., for the Gfap transcript expressed by reactive astrocytes and the chemokine Ccl3 transcript expressed by activated microglial cells). In conclusion, mild TBI chiefly activates transcripts leading to tissue signaling, inflammatory processes, and chemokine signaling, as in focal brain injury, suggesting putative targets for drug development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19317611      PMCID: PMC2989856          DOI: 10.1089/neu.2008.0676

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  23 in total

1.  The post concussional syndrome after mild head injury: some practical considerations.

Authors:  E Byrne
Journal:  J Clin Neurosci       Date:  2000-11       Impact factor: 1.961

Review 2.  Advanced monitoring in the neurology intensive care unit: microdialysis.

Authors:  Andrew J Johnston; Arun K Gupta
Journal:  Curr Opin Crit Care       Date:  2002-04       Impact factor: 3.687

Review 3.  Chemokines: key players in innate and adaptive immunity.

Authors:  Clemens Esche; Cristiana Stellato; Lisa A Beck
Journal:  J Invest Dermatol       Date:  2005-10       Impact factor: 8.551

Review 4.  The many roles of chemokines and chemokine receptors in inflammation.

Authors:  Israel F Charo; Richard M Ransohoff
Journal:  N Engl J Med       Date:  2006-02-09       Impact factor: 91.245

5.  Apoptotic changes in the cortex and hippocampus following minimal brain trauma in mice.

Authors:  Vadim Tashlykov; Yeshayahu Katz; Vered Gazit; Ofer Zohar; Shaul Schreiber; Chaim G Pick
Journal:  Brain Res       Date:  2006-12-14       Impact factor: 3.252

Review 6.  A systematic review of treatments for mild traumatic brain injury.

Authors:  P Comper; S M Bisschop; N Carnide; A Tricco
Journal:  Brain Inj       Date:  2005-10       Impact factor: 2.311

7.  Brain response to traumatic brain injury in wild-type and interleukin-6 knockout mice: a microarray analysis.

Authors:  Christian Bjørn Poulsen; Milena Penkowa; Rehannah Borup; Finn Cilius Nielsen; Mario Cáceres; Albert Quintana; Amalia Molinero; Javier Carrasco; Mercedes Giralt; Juan Hidalgo
Journal:  J Neurochem       Date:  2005-01       Impact factor: 5.372

8.  Altered expression of novel genes in the cerebral cortex following experimental brain injury.

Authors:  Nobuhide Kobori; Guy L Clifton; Pramod Dash
Journal:  Brain Res Mol Brain Res       Date:  2002-08-15

Review 9.  Traumatic injury to the immature brain: inflammation, oxidative injury, and iron-mediated damage as potential therapeutic targets.

Authors:  Mathew B Potts; Seong-Eun Koh; William D Whetstone; Breset A Walker; Tomoko Yoneyama; Catherine P Claus; Hovhannes M Manvelyan; Linda J Noble-Haeusslein
Journal:  NeuroRx       Date:  2006-04

10.  Genomic responses in rat cerebral cortex after traumatic brain injury.

Authors:  Christina von Gertten; Amilcar Flores Morales; Staffan Holmin; Tiit Mathiesen; Ann-Christin Sandberg Nordqvist
Journal:  BMC Neurosci       Date:  2005-11-30       Impact factor: 3.288

View more
  29 in total

1.  Mild traumatic brain injury-induced hippocampal gene expressions: The identification of target cellular processes for drug development.

Authors:  David Tweedie; Lital Rachmany; Dong Seok Kim; Vardit Rubovitch; Elin Lehrmann; Yongqing Zhang; Kevin G Becker; Evelyn Perez; Chaim G Pick; Nigel H Greig
Journal:  J Neurosci Methods       Date:  2016-02-08       Impact factor: 2.390

Review 2.  Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases.

Authors:  Kathryn A Frankola; Nigel H Greig; Weiming Luo; David Tweedie
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-05       Impact factor: 4.388

3.  Genetic activation of mTORC1 signaling worsens neurocognitive outcome after traumatic brain injury.

Authors:  Natalia S Rozas; John B Redell; Julia L Hill; James McKenna; Anthony N Moore; Michael J Gambello; Pramod K Dash
Journal:  J Neurotrauma       Date:  2014-12-10       Impact factor: 5.269

4.  Chronic exposure to the chemokine CCL3 enhances neuronal network activity in rat hippocampal cultures.

Authors:  M Kuijpers; K L I van Gassen; P N E de Graan; D Gruol
Journal:  J Neuroimmunol       Date:  2010-08-01       Impact factor: 3.478

Review 5.  Inflammatory reaction after traumatic brain injury: therapeutic potential of targeting cell-cell communication by chemokines.

Authors:  Stefka Gyoneva; Richard M Ransohoff
Journal:  Trends Pharmacol Sci       Date:  2015-05-13       Impact factor: 14.819

6.  Exendin-4, a glucagon-like peptide-1 receptor agonist prevents mTBI-induced changes in hippocampus gene expression and memory deficits in mice.

Authors:  David Tweedie; Lital Rachmany; Vardit Rubovitch; Elin Lehrmann; Yongqing Zhang; Kevin G Becker; Evelyn Perez; Jonathan Miller; Barry J Hoffer; Nigel H Greig; Chaim G Pick
Journal:  Exp Neurol       Date:  2012-10-08       Impact factor: 5.330

7.  Tumor necrosis factor-α synthesis inhibitor, 3,6'-dithiothalidomide, reverses behavioral impairments induced by minimal traumatic brain injury in mice.

Authors:  Renana Baratz; David Tweedie; Vardit Rubovitch; Weiming Luo; Jeong Seon Yoon; Barry J Hoffer; Nigel H Greig; Chaim G Pick
Journal:  J Neurochem       Date:  2011-08-05       Impact factor: 5.372

8.  Hemorrhagic shock shifts the serum cytokine profile from pro- to anti-inflammatory after experimental traumatic brain injury in mice.

Authors:  Steven L Shein; David K Shellington; Jennifer L Exo; Travis C Jackson; Stephen R Wisniewski; Edwin K Jackson; Vincent A Vagni; Hülya Bayır; Robert S B Clark; C Edward Dixon; Keri L Janesko-Feldman; Patrick M Kochanek
Journal:  J Neurotrauma       Date:  2014-08-15       Impact factor: 5.269

9.  Changes in mouse cognition and hippocampal gene expression observed in a mild physical- and blast-traumatic brain injury.

Authors:  David Tweedie; Lital Rachmany; Vardit Rubovitch; Yongqing Zhang; Kevin G Becker; Evelyn Perez; Barry J Hoffer; Chaim G Pick; Nigel H Greig
Journal:  Neurobiol Dis       Date:  2013-02-27       Impact factor: 5.996

10.  Analysis of functional pathways altered after mild traumatic brain injury.

Authors:  John B Redell; Anthony N Moore; Raymond J Grill; Daniel Johnson; Jing Zhao; Yin Liu; Pramod K Dash
Journal:  J Neurotrauma       Date:  2013-05-07       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.